1529-0131a/asset/cover.gif?v=1&s=4b71f39689e424fbb0e6725b1c033cc646a4272b "Arthritis Care & Research")
Dr. Choi has received consulting fees (less than $10,000 each) from TAP Pharmaceuticals and Savient Pharmaceuticals. Drs. Choi and Curhan have received grants from TAP Pharmaceuticals.
2151-4658/asset/olbannerleft.gif?v=1&s=75d1dd4933b4687fdb365bb32190b0a4ef453ee7)
2151-4658/asset/olbannerright.gif?v=1&s=a36ba6af41bd9af370864f6461a516746a709d31)
Original Article
You have full text access to this OnlineOpen article
Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey
Article first published online: 31 JAN 2007
DOI: 10.1002/art.22466
Copyright © 2007 by the American College of Rheumatology
Additional Information
How to Cite
Choi, H. K., Ford, E. S., Li, C. and Curhan, G. (2007), Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey. Arthritis & Rheumatism, 57: 109–115. doi: 10.1002/art.22466
Publication History
- Issue published online: 31 JAN 2007
- Article first published online: 31 JAN 2007
- Manuscript Accepted: 11 MAY 2006
- Manuscript Received: 2 MAR 2006
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008, The American Journal of Medicine, 2012,
- 2, , , , , Increased prevalence of simple renal cysts in patients with gout, Rheumatology International, 2012,
- 3, , , , , , , , , , National prevalence of gout derived from administrative health data in Aotearoa New Zealand, Rheumatology, 2012, 51, 5, 901
- 4, , , , , , , , , , RNA modifications by oxidation: A novel disease mechanism?, Free Radical Biology and Medicine, 2012, 52, 8, 1353
- 5, , , , , , Uric Acid is an Important Predictor for Hypertensive Early Atherosclerosis, Advances in Therapy, 2012, 29, 3, 276
- 6
- 7
- 8, , , , Contemporary epidemiology of gout in the UK general population, Arthritis Research & Therapy, 2011, 13, 2, R39
- 9
- 10, , , , , , , , Elevated risk of mortality among gout patients: A comparison with the National Population in Taiwan, Joint Bone Spine, 2011, 78, 6, 577
- 11, , , , , Gender-specific risk factors for incident gout: a prospective cohort study, Clinical Rheumatology, 2011, 31, 2, 239
- 12, , , , , , , , , Gout and Type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences, Rheumatology, 2011, 51, 4, 715
- 13
- 14, , , , , , , , , Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout, The American Journal of Medicine, 2011, 124, 2, 155
- 15, , , Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007–2008, Arthritis & Rheumatism, 2011, 63, 10Direct Link:
- 16
- 17, Rising Gout, Life Threatening Public Enemy, Journal of Rheumatic Diseases, 2011, 18, 4, 234
- 18, , , , , , , , Risqué élevé de mortalité chez les patients goutteux : une comparaison avec la population nationale taïwanaise, Revue du Rhumatisme, 2011, 78, 5, 437
- 19, , Role of Diet in Rheumatic Disease, Rheumatic Disease Clinics of North America, 2011, 37, 1, 119
- 20, , , The Effect of Hypouricemic Treatment on the Renal Function in Patients with Gout, Journal of Rheumatic Diseases, 2011, 18, 1, 26
- 21
- 22
- 23, , The Patient’s Experience of Gout: New Insights to Optimize Management, Current Rheumatology Reports, 2011, 14, 2, 173
- 24, , The Prevalence and Features of Korean Gout Patients Using the National Health Insurance Corporation Database, Journal of Rheumatic Diseases, 2011, 18, 2, 94
- 25, , Uric acid in heart disease: a new C-reactive protein?, Current Opinion in Rheumatology, 2011, 23, 2, 174
- 26, A prescription for lifestyle change in patients with hyperuricemia and gout, Current Opinion in Rheumatology, 2010, 22, 2, 165
- 27, , Bases génétiques de l’hyperuricémie et de la goutte, Revue du Rhumatisme Monographies, 2010, 77, 4, 328
- 28, , , Body composition and metabolic syndrome in patients with primary gout in Vietnam, Rheumatology, 2010, 49, 12, 2400
- 29, Current and Future Therapeutic Options for the Management of Gout, American Journal of Therapeutics, 2010, 1
- 30, , Effects of Dairy Intake on Hyperuricemia and Gout, Current Rheumatology Reports, 2010, 13, 2, 132
- 31, , , , Epidemiology of gout: An update, Best Practice & Research Clinical Rheumatology, 2010, 24, 6, 811
- 32
- 33
- 34, , , , , , , , , , Gout and risk of non-alcoholic fatty liver disease, Scandinavian Journal of Rheumatology, 2010, 39, 6, 466
- 35, , , , , , Increased Frequency of Metabolic Syndrome and Its Individual Metabolic Abnormalities in Japanese Patients With Primary Gout, JCR: Journal of Clinical Rheumatology, 2010, 16, 3, 109
- 36, , , , , , , Metabolic Syndrome Characteristics in Gout Patients, Nucleosides, Nucleotides and Nucleic Acids, 2010, 29, 4-6, 325
- 37, , Rheumatic Manifestations of Diabetes Mellitus, Rheumatic Disease Clinics of North America, 2010, 36, 4, 681
- 38, , , , , , , , Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo, Proceedings of the National Academy of Sciences, 2010, 107, 32, 14351
- 39, , Unusual clinical presentations of gout, Current Opinion in Rheumatology, 2010, 22, 2, 181
- 40, , , , , , , , First Acute Gout Attacks Commonly Precede Features of the Metabolic Syndrome, JCR: Journal of Clinical Rheumatology, 2009, 15, 2, 65
- 41, , , , , Gout Study Group: Update on hyperuricemia and gout, Joint Bone Spine, 2009, 76, 4, 444
- 42, , , , , , , , , Gout: an independent risk factor for all-cause and cardiovascular mortality, Rheumatology, 2009, 49, 1, 141
- 43, , Gout: new advances in the diagnosis and management of an old disease, International Journal of Clinical Rheumatology, 2009, 4, 2, 203
- 44, , Imaging gout: brought back to the forefront with dual-energy computed tomography, Imaging in Medicine, 2009, 1, 2, 119
- 45, , , Kristallinduzierte Inflammasomaktivierung: Gicht und Pseudogicht, Zeitschrift für Rheumatologie, 2009, 68, 9, 733
- 46
- 47
- 48, , , , Prescription and comorbidity screening following consultation for acute gout in primary care, Rheumatology, 2009, 49, 1, 105
- 49, , , , , Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: A chinese cohort study, Arthritis Care & Research, 2009, 61, 2Direct Link:
- 50, , Update on factors predisposing to gout, International Journal of Clinical Rheumatology, 2009, 4, 1, 75
- 51, , Crystal ball gazing: new therapeutic targets for hyperuricaemia and gout, Rheumatology, 2008, 48, 3, 222
- 52
- 53, , , Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile, Rheumatology, 2008, 47, 10, 1567
- 54, , , How PCP Education Can Impact Gout Management, JCR: Journal of Clinical Rheumatology, 2008, 14, Supplement, S42
- 55, , Hyperuricemia, gout and the metabolic syndrome, Current Opinion in Rheumatology, 2008, 20, 2, 187
- 56
- 57, , , , Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: The third national health and nutrition examination survey, Arthritis Care & Research, 2008, 59, 1Direct Link:
- 58High prevalence of metabolic syndrome in patients with gout or SLE, Nature Clinical Practice Rheumatology, 2007, 3, 5, 250
- 59, , Prevalence of the Metabolic Syndrome in Individuals with Hyperuricemia, The American Journal of Medicine, 2007, 120, 5, 442
- 60, , Bone and Rheumatic Disorders in Diabetes,Direct Link: